Potentiation of temozolomide antitumor effect by purine receptor ligands able to restrain the in vitro growth of human glioblastoma stem cells. [electronic resource]
Producer: 20160524Description: 331-46 p. digitalISSN:- 1573-9546
- Adenosine A3 Receptor Antagonists -- pharmacology
- Adenosine Triphosphate -- analogs & derivatives
- Antineoplastic Agents, Alkylating -- pharmacology
- Apoptosis -- drug effects
- Brain Neoplasms -- drug therapy
- Caspase Inhibitors -- pharmacology
- Cell Proliferation
- Dacarbazine -- analogs & derivatives
- Drug Synergism
- Glioblastoma -- drug therapy
- Humans
- Ligands
- Neoplastic Stem Cells -- drug effects
- Purinergic P2Y Receptor Antagonists -- pharmacology
- Receptors, Purinergic -- drug effects
- Receptors, Purinergic P1 -- drug effects
- Receptors, Purinergic P2X7 -- drug effects
- Temozolomide
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.